Despite the passage of a 2010 law addressing such medicines, the Food and Drug Administration’s (FDA) approval this year of the first biosimilar has prompted a flurry of regulatory activity aimed at filling gaps left by the statute. For a helpful primer
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/12/14/implementation-of-the-biosimilars-provisions-of-the-aca-where-are-we-now/
Posted
Dec 14 2015, 08:38 AM
by
Health Affairs Blog